Global Pet Pharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 103

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Pet Pharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pet Pharmaceuticals size is estimated to be XX million in 2021 from USD 13790 million in 2020, with a change of XX% between 2020 and 2021. The global Pet Pharmaceuticals market size is expected to grow at a CAGR of 6.7% for the next five years.

Market segmentation
Pet Pharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Antiparasitic
    Biological Products
    Antibacterial
    Others

Market segment by Application can be divided into
    Prevention
    Treatment

The key market players for global Pet Pharmaceuticals market are listed below:
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pet Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Pharmaceuticals, with price, sales, revenue and global market share of Pet Pharmaceuticals from 2019 to 2021.
Chapter 3, the Pet Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pet Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pet Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Pet Pharmaceuticals Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Pet Pharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Antiparasitic
        1.2.3 Biological Products
        1.2.4 Antibacterial
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Pet Pharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Prevention
        1.3.3 Treatment
    1.4 Global Pet Pharmaceuticals Market Size & Forecast
        1.4.1 Global Pet Pharmaceuticals Sales in Value (2016-2026))
        1.4.2 Global Pet Pharmaceuticals Sales in Volume (2016-2026)
        1.4.3 Global Pet Pharmaceuticals Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Pet Pharmaceuticals Production Capacity Analysis
        1.5.1 Global Pet Pharmaceuticals Total Production Capacity (2016-2026)
        1.5.2 Global Pet Pharmaceuticals Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pet Pharmaceuticals Market Drivers
        1.6.2 Pet Pharmaceuticals Market Restraints
        1.6.3 Pet Pharmaceuticals Trends Analysis

2 Manufacturers Profiles
    2.1 Zoetis
        2.1.1 Zoetis Details
        2.1.2 Zoetis Major Business
        2.1.3 Zoetis Pet Pharmaceuticals Product and Services
        2.1.4 Zoetis Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Boehringer Ingelheim
        2.2.1 Boehringer Ingelheim Details
        2.2.2 Boehringer Ingelheim Major Business
        2.2.3 Boehringer Ingelheim Pet Pharmaceuticals Product and Services
        2.2.4 Boehringer Ingelheim Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Pet Pharmaceuticals Product and Services
        2.3.4 Merck Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Elanco
        2.4.1 Elanco Details
        2.4.2 Elanco Major Business
        2.4.3 Elanco Pet Pharmaceuticals Product and Services
        2.4.4 Elanco Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Virbac
        2.5.1 Virbac Details
        2.5.2 Virbac Major Business
        2.5.3 Virbac Pet Pharmaceuticals Product and Services
        2.5.4 Virbac Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Dechra Veterinary Products
        2.6.1 Dechra Veterinary Products Details
        2.6.2 Dechra Veterinary Products Major Business
        2.6.3 Dechra Veterinary Products Pet Pharmaceuticals Product and Services
        2.6.4 Dechra Veterinary Products Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Ceva
        2.7.1 Ceva Details
        2.7.2 Ceva Major Business
        2.7.3 Ceva Pet Pharmaceuticals Product and Services
        2.7.4 Ceva Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Vetoquinol
        2.8.1 Vetoquinol Details
        2.8.2 Vetoquinol Major Business
        2.8.3 Vetoquinol Pet Pharmaceuticals Product and Services
        2.8.4 Vetoquinol Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Ouro Fino Saude
        2.9.1 Ouro Fino Saude Details
        2.9.2 Ouro Fino Saude Major Business
        2.9.3 Ouro Fino Saude Pet Pharmaceuticals Product and Services
        2.9.4 Ouro Fino Saude Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Norbrook
        2.10.1 Norbrook Details
        2.10.2 Norbrook Major Business
        2.10.3 Norbrook Pet Pharmaceuticals Product and Services
        2.10.4 Norbrook Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Jindun
        2.11.1 Jindun Details
        2.11.2 Jindun Major Business
        2.11.3 Jindun Pet Pharmaceuticals Product and Services
        2.11.4 Jindun Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Chopperlvya Animal Health
        2.12.1 Chopperlvya Animal Health Details
        2.12.2 Chopperlvya Animal Health Major Business
        2.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Product and Services
        2.12.4 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 CAHIC
        2.13.1 CAHIC Details
        2.13.2 CAHIC Major Business
        2.13.3 CAHIC Pet Pharmaceuticals Product and Services
        2.13.4 CAHIC Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Pet Pharmaceuticals Sales by Manufacturer
    3.1 Global Pet Pharmaceuticals Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Pet Pharmaceuticals Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Pet Pharmaceuticals
    3.4 Market Concentration Rate
        3.4.1 Top 3 Pet Pharmaceuticals Manufacturer Market Share
        3.4.2 Top 6 Pet Pharmaceuticals Manufacturer Market Share
    3.5 Global Pet Pharmaceuticals Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Pet Pharmaceuticals Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Pet Pharmaceuticals Market Size by Region
        4.1.1 Global Pet Pharmaceuticals Sales in Volume by Region (2016-2026)
        4.1.2 Global Pet Pharmaceuticals Revenue by Region (2016-2026)
    4.2 North America Pet Pharmaceuticals Revenue (2016-2026)
    4.3 Europe Pet Pharmaceuticals Revenue (2016-2026)
    4.4 Asia-Pacific Pet Pharmaceuticals Revenue (2016-2026)
    4.5 South America Pet Pharmaceuticals Revenue (2016-2026)
    4.6 Middle East and Africa Pet Pharmaceuticals Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Pet Pharmaceuticals Sales in Volume by Type (2016-2026)
    5.2 Global Pet Pharmaceuticals Revenue by Type (2016-2026)
    5.3 Global Pet Pharmaceuticals Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Pet Pharmaceuticals Sales in Volume by Application (2016-2026)
    6.2 Global Pet Pharmaceuticals Revenue by Application (2016-2026)
    6.3 Global Pet Pharmaceuticals Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Pet Pharmaceuticals Sales by Type (2016-2026)
    7.2 North America Pet Pharmaceuticals Sales by Application (2016-2026)
    7.3 North America Pet Pharmaceuticals Market Size by Country
        7.3.1 North America Pet Pharmaceuticals Sales in Volume by Country (2016-2026)
        7.3.2 North America Pet Pharmaceuticals Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Pet Pharmaceuticals Sales by Type (2016-2026)
    8.2 Europe Pet Pharmaceuticals Sales by Application (2016-2026)
    8.3 Europe Pet Pharmaceuticals Market Size by Country
        8.3.1 Europe Pet Pharmaceuticals Sales in Volume by Country (2016-2026)
        8.3.2 Europe Pet Pharmaceuticals Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Pet Pharmaceuticals Sales by Type (2016-2026)
    9.2 Asia-Pacific Pet Pharmaceuticals Sales by Application (2016-2026)
    9.3 Asia-Pacific Pet Pharmaceuticals Market Size by Region
        9.3.1 Asia-Pacific Pet Pharmaceuticals Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Pet Pharmaceuticals Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Pet Pharmaceuticals Sales by Type (2016-2026)
    10.2 South America Pet Pharmaceuticals Sales by Application (2016-2026)
    10.3 South America Pet Pharmaceuticals Market Size by Country
        10.3.1 South America Pet Pharmaceuticals Sales in Volume by Country (2016-2026)
        10.3.2 South America Pet Pharmaceuticals Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Pet Pharmaceuticals Sales by Type (2016-2026)
    11.2 Middle East & Africa Pet Pharmaceuticals Sales by Application (2016-2026)
    11.3 Middle East & Africa Pet Pharmaceuticals Market Size by Country
        11.3.1 Middle East & Africa Pet Pharmaceuticals Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Pet Pharmaceuticals Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Pet Pharmaceuticals Typical Distributors
    12.3 Pet Pharmaceuticals Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pet Pharmaceuticals Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Pet Pharmaceuticals Revenue by Application, (USD Million), 2021-2026
    Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 4. Zoetis Major Business
    Table 5. Zoetis Pet Pharmaceuticals Product and Services
    Table 6. Zoetis Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 8. Boehringer Ingelheim Major Business
    Table 9. Boehringer Ingelheim Pet Pharmaceuticals Product and Services
    Table 10. Boehringer Ingelheim Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Merck Basic Information, Manufacturing Base and Competitors
    Table 12. Merck Major Business
    Table 13. Merck Pet Pharmaceuticals Product and Services
    Table 14. Merck Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Elanco Basic Information, Manufacturing Base and Competitors
    Table 16. Elanco Major Business
    Table 17. Elanco Pet Pharmaceuticals Product and Services
    Table 18. Elanco Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Virbac Basic Information, Manufacturing Base and Competitors
    Table 20. Virbac Major Business
    Table 21. Virbac Pet Pharmaceuticals Product and Services
    Table 22. Virbac Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
    Table 24. Dechra Veterinary Products Major Business
    Table 25. Dechra Veterinary Products Pet Pharmaceuticals Product and Services
    Table 26. Dechra Veterinary Products Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Ceva Basic Information, Manufacturing Base and Competitors
    Table 28. Ceva Major Business
    Table 29. Ceva Pet Pharmaceuticals Product and Services
    Table 30. Ceva Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Vetoquinol Basic Information, Manufacturing Base and Competitors
    Table 32. Vetoquinol Major Business
    Table 33. Vetoquinol Pet Pharmaceuticals Product and Services
    Table 34. Vetoquinol Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
    Table 36. Ouro Fino Saude Major Business
    Table 37. Ouro Fino Saude Pet Pharmaceuticals Product and Services
    Table 38. Ouro Fino Saude Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Norbrook Basic Information, Manufacturing Base and Competitors
    Table 40. Norbrook Major Business
    Table 41. Norbrook Pet Pharmaceuticals Product and Services
    Table 42. Norbrook Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Jindun Basic Information, Manufacturing Base and Competitors
    Table 44. Jindun Major Business
    Table 45. Jindun Pet Pharmaceuticals Product and Services
    Table 46. Jindun Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Chopperlvya Animal Health Basic Information, Manufacturing Base and Competitors
    Table 48. Chopperlvya Animal Health Major Business
    Table 49. Chopperlvya Animal Health Pet Pharmaceuticals Product and Services
    Table 50. Chopperlvya Animal Health Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. CAHIC Basic Information, Manufacturing Base and Competitors
    Table 52. CAHIC Major Business
    Table 53. CAHIC Pet Pharmaceuticals Product and Services
    Table 54. CAHIC Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. Global Pet Pharmaceuticals Sales by Manufacturer (2019-2021e) & (K Units)
    Table 56. Global Pet Pharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 57. Market Position of Manufacturers in Pet Pharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 58. Global Pet Pharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021
    Table 59. Head Office and Pet Pharmaceuticals Production Site of Key Manufacturer
    Table 60. Pet Pharmaceuticals New Entrant and Capacity Expansion Plans
    Table 61. Pet Pharmaceuticals Mergers & Acquisitions in the Past Five Years
    Table 62. Global Pet Pharmaceuticals Sales by Region (2016-2021e) & (K Units)
    Table 63. Global Pet Pharmaceuticals Sales by Region (2021-2026) & (K Units)
    Table 64. Global Pet Pharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
    Table 65. Global Pet Pharmaceuticals Revenue by Region (2021-2026) & (USD Million)
    Table 66. Global Pet Pharmaceuticals Sales by Type (2016-2021e) & (K Units)
    Table 67. Global Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units)
    Table 68. Global Pet Pharmaceuticals Revenue by Type (2016-2021e) & (USD Million)
    Table 69. Global Pet Pharmaceuticals Revenue by Type (2021-2026) & (USD Million)
    Table 70. Global Pet Pharmaceuticals Price by Type (2016-2021e) & (US$/Unit)
    Table 71. Global Pet Pharmaceuticals Price by Type (2021-2026) & (US$/Unit)
    Table 72. Global Pet Pharmaceuticals Sales by Application (2016-2021e) & (K Units)
    Table 73. Global Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units)
    Table 74. Global Pet Pharmaceuticals Revenue by Application (2016-2021e) & (USD Million)
    Table 75. Global Pet Pharmaceuticals Revenue by Application (2021-2026) & (USD Million)
    Table 76. Global Pet Pharmaceuticals Price by Application (2016-2021e) & (US$/Unit)
    Table 77. Global Pet Pharmaceuticals Price by Application (2021-2026) & (US$/Unit)
    Table 78. North America Pet Pharmaceuticals Sales by Country (2016-2021e) & (K Units)
    Table 79. North America Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units)
    Table 80. North America Pet Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
    Table 81. North America Pet Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
    Table 82. North America Pet Pharmaceuticals Sales by Type (2016-2021e) & (K Units)
    Table 83. North America Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units)
    Table 84. North America Pet Pharmaceuticals Sales by Application (2016-2021e) & (K Units)
    Table 85. North America Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units)
    Table 86. Europe Pet Pharmaceuticals Sales by Country (2016-2021e) & (K Units)
    Table 87. Europe Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units)
    Table 88. Europe Pet Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
    Table 89. Europe Pet Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
    Table 90. Europe Pet Pharmaceuticals Sales by Type (2016-2021e) & (K Units)
    Table 91. Europe Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units)
    Table 92. Europe Pet Pharmaceuticals Sales by Application (2016-2021e) & (K Units)
    Table 93. Europe Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units)
    Table 94. Asia-Pacific Pet Pharmaceuticals Sales by Region (2016-2021e) & (K Units)
    Table 95. Asia-Pacific Pet Pharmaceuticals Sales by Region (2021-2026) & (K Units)
    Table 96. Asia-Pacific Pet Pharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
    Table 97. Asia-Pacific Pet Pharmaceuticals Revenue by Region (2021-2026) & (USD Million)
    Table 98. Asia-Pacific Pet Pharmaceuticals Sales by Type (2016-2021e) & (K Units)
    Table 99. Asia-Pacific Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units)
    Table 100. Asia-Pacific Pet Pharmaceuticals Sales by Application (2016-2021e) & (K Units)
    Table 101. Asia-Pacific Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units)
    Table 102. South America Pet Pharmaceuticals Sales by Country (2016-2021e) & (K Units)
    Table 103. South America Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units)
    Table 104. South America Pet Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
    Table 105. South America Pet Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
    Table 106. South America Pet Pharmaceuticals Sales by Type (2016-2021e) & (K Units)
    Table 107. South America Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units)
    Table 108. South America Pet Pharmaceuticals Sales by Application (2016-2021e) & (K Units)
    Table 109. South America Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units)
    Table 110. Middle East & Africa Pet Pharmaceuticals Sales by Country (2016-2021e) & (K Units)
    Table 111. Middle East & Africa Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units)
    Table 112. Middle East & Africa Pet Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
    Table 113. Middle East & Africa Pet Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
    Table 114. Middle East & Africa Pet Pharmaceuticals Sales by Type (2016-2021e) & (K Units)
    Table 115. Middle East & Africa Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units)
    Table 116. Middle East & Africa Pet Pharmaceuticals Sales by Application (2016-2021e) & (K Units)
    Table 117. Middle East & Africa Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units)
    Table 118. Direct Channel Pros & Cons
    Table 119. Indirect Channel Pros & Cons
    Table 120. Pet Pharmaceuticals Typical Distributors
    Table 121. Pet Pharmaceuticals Typical Customers
List of Figures
    Figure 1. Pet Pharmaceuticals Picture
    Figure 2. Global Pet Pharmaceuticals Sales Market Share by Type in 2020
    Figure 3. Antiparasitic
    Figure 4. Biological Products
    Figure 5. Antibacterial
    Figure 6. Others
    Figure 7. Global Pet Pharmaceuticals Sales Market Share by Application in 2020
    Figure 8. Prevention
    Figure 9. Treatment
    Figure 10. Global Pet Pharmaceuticals Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 11. Global Pet Pharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Pet Pharmaceuticals Sales (2016-2026) & (K Units)
    Figure 13. Global Pet Pharmaceuticals Price by Type (2016-2026) & (US$/Unit)
    Figure 14. Global Pet Pharmaceuticals Production Capacity (2016-2026) & (K Units)
    Figure 15. Global Pet Pharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021
    Figure 16. Pet Pharmaceuticals Market Drivers
    Figure 17. Pet Pharmaceuticals Market Restraints
    Figure 18. Pet Pharmaceuticals Market Trends
    Figure 19. Global Pet Pharmaceuticals Sales Market Share by Manufacturer in 2020
    Figure 20. Global Pet Pharmaceuticals Revenue Market Share by Manufacturer in 2020
    Figure 21. Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 22. Top 3 Pet Pharmaceuticals Manufacturer (Revenue) Market Share in 2020
    Figure 23. Top 6 Pet Pharmaceuticals Manufacturer (Revenue) Market Share in 2020
    Figure 24. Global Pet Pharmaceuticals Sales Market Share by Region (2016-2026)
    Figure 25. Global Pet Pharmaceuticals Revenue Market Share by Region (2016-2026)
    Figure 26. North America Pet Pharmaceuticals Revenue (2016-2026) & (USD Million)
    Figure 27. Europe Pet Pharmaceuticals Revenue (2016-2026) & (USD Million)
    Figure 28. Asia-Pacific Pet Pharmaceuticals Revenue (2016-2026) & (USD Million)
    Figure 29. South America Pet Pharmaceuticals Revenue (2016-2026) & (USD Million)
    Figure 30. Middle East & Africa Pet Pharmaceuticals Revenue (2016-2026) & (USD Million)
    Figure 31. Global Pet Pharmaceuticals Sales Market Share by Type (2016-2026)
    Figure 32. Global Pet Pharmaceuticals Revenue Market Share by Type (2016-2026)
    Figure 33. Global Pet Pharmaceuticals Price by Type (2016-2026) & (US$/Unit)
    Figure 34. Global Pet Pharmaceuticals Sales Market Share by Application (2016-2026)
    Figure 35. Global Pet Pharmaceuticals Revenue Market Share by Application (2016-2026)
    Figure 36. Global Pet Pharmaceuticals Price by Application (2016-2026) & (US$/Unit)
    Figure 37. North America Pet Pharmaceuticals Sales Market Share by Type (2016-2026)
    Figure 38. North America Pet Pharmaceuticals Sales Market Share by Application (2016-2026)
    Figure 39. North America Pet Pharmaceuticals Sales Market Share by Country (2016-2026)
    Figure 40. North America Pet Pharmaceuticals Revenue Market Share by Country (2016-2026)
    Figure 41. United States Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Canada Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Mexico Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Europe Pet Pharmaceuticals Sales Market Share by Type (2016-2026)
    Figure 45. Europe Pet Pharmaceuticals Sales Market Share by Application (2016-2026)
    Figure 46. Europe Pet Pharmaceuticals Sales Market Share by Country (2016-2026)
    Figure 47. Europe Pet Pharmaceuticals Revenue Market Share by Country (2016-2026)
    Figure 48. Germany Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. France Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. United Kingdom Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Russia Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Italy Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Asia-Pacific Pet Pharmaceuticals Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific Pet Pharmaceuticals Sales Market Share by Application (2016-2026)
    Figure 55. Asia-Pacific Pet Pharmaceuticals Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Pet Pharmaceuticals Revenue Market Share by Region (2016-2026)
    Figure 57. China Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Japan Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Korea Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. India Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Southeast Asia Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Australia Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South America Pet Pharmaceuticals Sales Market Share by Type (2016-2026)
    Figure 64. South America Pet Pharmaceuticals Sales Market Share by Application (2016-2026)
    Figure 65. South America Pet Pharmaceuticals Sales Market Share by Country (2016-2026)
    Figure 66. South America Pet Pharmaceuticals Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East & Africa Pet Pharmaceuticals Sales Market Share by Type (2016-2026)
    Figure 70. Middle East & Africa Pet Pharmaceuticals Sales Market Share by Application (2016-2026)
    Figure 71. Middle East & Africa Pet Pharmaceuticals Sales Market Share by Country (2016-2026)
    Figure 72. Middle East & Africa Pet Pharmaceuticals Revenue Market Share by Country (2016-2026)
    Figure 73. Turkey Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Egypt Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Saudi Arabia Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. South Africa Pet Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Sales Channel: Direct Channel vs Indirect Channel
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC

Related Reports

Global Pet Pharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Pet Pharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Pet Pharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Pet Pharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pet Pharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Pet pharmaceutical refers specifically to medicines given to pets.

Global Pet Pharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pet Pharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pet Pharmaceuticals market size was valued at USD 14680 million in 2023 and is forecast to a readjusted size of USD 23120 million by 2030 with a CAGR of 6.7% during review period.

Global Pet Pharmaceuticals Supply, Demand and Key Producers, 2024-2030

Global Pet Pharmaceuticals Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

The global Pet Pharmaceuticals market size is expected to reach $ 23120 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>